DOES REAL-WORLD EVIDENCE PLAY A ROLE IN DECISION-MAKING BY HTA BODIES FOR MEDICAL TECHNOLOGIES?

被引：0
|
作者：
Hartley, L. [1 ]
Gildea, L. [1 ]
Mordin, M. [2 ]
Long, J. [1 ]
D'Souza, V [1 ]
Kinderas, M. [3 ]
Ling, C. [1 ]
Warttig, S. [1 ]
机构：
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] RTI Hlth Solut, Oak Hill, VA USA
[3] RTI Hlth Solut, Ljungskile, Sweden
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MT43
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [31] Real-World Evidence in Regulatory Decision Making: Time for Evidence Integration
    Miksad, Rebecca A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (05) : 1153 - 1155
  • [32] DOES REAL WORLD EVIDENCE SUPPORT CONCLUSIONS FROM EXPERIMENTAL EVIDENCE IN DECISION-MAKING PROCESSES IN POLAND?
    Wilk, N.
    Wierzbicka, N.
    Skrzekowska-Baran, I
    Mocko, P.
    Tomassy, J.
    Kloc, K.
    VALUE IN HEALTH, 2016, 19 (07) : A449 - A449
  • [33] The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report
    Bollaerts, Kaatje
    Wyndham-Thomas, Chloe
    Miller, Elizabeth
    Izurieta, Hector S.
    Black, Steve
    Andrews, Nick
    Rubbrecht, Michelle
    Van Heuverswyn, Fran
    Neels, Pieter
    BIOLOGICALS, 2024, 85
  • [34] ANALYSIS OF REAL-WORLD EVIDENCE AND REAL-WORLD DATA BY CONITEC, BRAZILIAN HTA AGENCY
    Nita, M. E.
    Riveros, B. S.
    Vaz, P.
    Mussolino, F.
    VALUE IN HEALTH, 2016, 19 (03) : A286 - A286
  • [35] Randomized Trials vs Real-world Evidence How Can Both Inform Decision-making?
    Sheldrick, R. Christopher
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (16): : 1352 - 1353
  • [36] Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
    Burcu, Mehmet
    Dreyer, Nancy A.
    Franklin, Jessica M.
    Blum, Michael D.
    Critchlow, Cathy W.
    Perfetto, Eleanor M.
    Zhou, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1228 - 1235
  • [37] CAN YOU DESIGN AND CONDUCT A REAL-WORLD EVIDENCE STUDY THAT IS TRANSFERABLE BETWEEN HTA BODIES?
    Kolovos, S.
    Gaultney, J.
    Leproust, S.
    Guerra, I
    VALUE IN HEALTH, 2022, 25 (12) : S4 - S5
  • [38] HOW DOES REAL-WORLD EVIDENCE SUPPORT REGULATORY AND HTA AGENCY ASSESSMENTS AND BEYOND?
    Sam, L.
    Ong, A.
    Mckendrick, J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [39] Real-world data curation to transform medical investigation: Technology to reimagine the economics of evidence gathering and support regulatory decision-making
    Leibtag, Aaron
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2020, 23 : 44S - 47S
  • [40] Real-world evidence to support regulatory decision making: New or expanded medical product indications
    Franklin, Jessica M.
    Liaw, Kai-Li
    Iyasu, Solomon
    Critchlow, Cathy W.
    Dreyer, Nancy A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (06) : 685 - 693
12345